NervGen Pharma Corp. (NGEN)
2.13
-0.01
(-0.47%)
USD |
NASDAQ |
Sep 16, 16:00
2.07
-0.06
(-2.82%)
After-Hours: 07:20
NervGen Pharma Cash from Operations (Quarterly) : -4.086M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -4.086M |
| March 31, 2026 | -5.978M |
| December 31, 2025 | -4.470M |
| September 30, 2025 | -3.893M |
| June 30, 2025 | -2.750M |
| March 31, 2025 | -2.870M |
| December 31, 2024 | -2.379M |
| September 30, 2024 | -4.234M |
| June 30, 2024 | -3.022M |
| March 31, 2024 | -2.408M |
| December 31, 2023 | -2.171M |
| September 30, 2023 | -1.076M |
| June 30, 2023 | -1.512M |
| March 31, 2023 | -3.535M |
| December 31, 2022 | -3.349M |
| September 30, 2022 | -3.540M |
| June 30, 2022 | -2.871M |
| March 31, 2022 | -3.338M |
| Date | Value |
|---|---|
| December 31, 2021 | -2.263M |
| September 30, 2021 | -1.532M |
| June 30, 2021 | -1.748M |
| March 31, 2021 | -1.016M |
| December 31, 2020 | -1.571M |
| September 30, 2020 | -0.9437M |
| June 30, 2020 | -0.9078M |
| March 31, 2020 | -1.417M |
| December 31, 2019 | -1.523M |
| September 30, 2019 | -1.660M |
| June 30, 2019 | -1.001M |
| March 31, 2019 | -1.948M |
| December 31, 2018 | -0.521M |
| September 30, 2018 | -0.2409M |
| June 30, 2018 | |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| InMed Pharmaceuticals, Inc. | -2.909M |
| Milestone Pharmaceuticals, Inc. | -22.53M |
| Clearmind Medicine, Inc. | -1.859M |
| Lexaria Bioscience Corp. | -1.635M |
| Target Group, Inc. (Canada) | -0.2229M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.0001M |
| Cash from Financing (Quarterly) | 56.43M |
| Free Cash Flow | -18.43M |
| Free Cash Flow Per Share (Quarterly) | -0.0442 |
| Free Cash Flow to Equity (Quarterly) | -4.086M |
| Free Cash Flow to Firm (Quarterly) | -4.086M |
| Free Cash Flow Yield | -10.73% |